These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18231825)

  • 81. A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM).
    Williams K; George K; Hulton A; Godfrey R; Lahart I; Wilson MG; Charlesworth S; Warburton D; Gaze D; Whyte G
    Curr Med Chem; 2011; 18(23):3446-51. PubMed ID: 21756241
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure.
    Setsuta K; Seino Y; Kitahara Y; Arau M; Ohbayashi T; Takano T; Mizuno K
    Circ J; 2008 Apr; 72(4):569-74. PubMed ID: 18362427
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia.
    Tambara K; Fujita M; Miyamoto S; Doi K; Nishimura K; Komeda M
    Int J Cardiol; 2004 Feb; 93(2-3):281-4. PubMed ID: 14975559
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Elevated Serum Liver Enzymes in Patients with Obstructive Sleep Apnea-hypopnea Syndrome.
    Li J; Zhang YL; Chen R; Wang Y; Xiong KP; Huang JY; Han F; Liu CF
    Chin Med J (Engl); 2015 Nov; 128(22):2983-7. PubMed ID: 26608975
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gender differences on polysomnographic findings in Greek subjects with obstructive sleep apnea syndrome.
    Vagiakis E; Kapsimalis F; Lagogianni I; Perraki H; Minaritzoglou A; Alexandropoulou K; Roussos C; Kryger M
    Sleep Med; 2006 Aug; 7(5):424-30. PubMed ID: 16740405
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
    Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values.
    Liyan C; Jie Z; Xiaozhou H
    J Clin Lab Anal; 2009; 23(1):14-8. PubMed ID: 19140206
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Study on the Role of Heart Type Fatty Acid Binding Protein in the Diagnosis of Acute Myocardial Infarction.
    Kabekkodu SP; Mananje SR; Saya RP
    J Clin Diagn Res; 2016 Jan; 10(1):OC07-10. PubMed ID: 26894106
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Heart-type fatty acid binding protein for the assessment of the short-term prognosis in acute pulmonary embolism patients with hemodynamic stability on admission].
    Chen Y; Liu S; Guo W; Wang ZZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):516-21. PubMed ID: 24262088
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
    J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A positive correlation between adipocyte fatty acid binding protein and epicardial fat thickness in patients with obstructive sleep apnoea - preliminary data.
    Sova M; Genzor S; Sovova E; Amjad Ghazal A; Nadjarpour S
    Neuro Endocrinol Lett; 2020 Dec; 41(5):239-244. PubMed ID: 33315335
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics.
    Niizeki T; Takeishi Y; Takabatake N; Shibata Y; Konta T; Kato T; Kawata S; Kubota I
    Circ J; 2007 Sep; 71(9):1452-7. PubMed ID: 17721027
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Trajectories of interleukin 10 and heart fatty acid-binding protein levels in traumatic brain injury patients with or without extracranial injuries.
    Niiranen TJU; Chiollaz AC; Takala RSK; Voutilainen M; Tenovuo O; Newcombe VFJ; Maanpää HR; Tallus J; Mohammadian M; Hossain I; van Gils M; Menon DK; Hutchinson PJ; Sanchez JC; Posti JP
    Front Neurol; 2023; 14():1133764. PubMed ID: 37082447
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Thrombolysis in patients with pulmonary embolism and elevated heart-type fatty acid-binding protein levels.
    Gul EE; Can I; Kayrak M; Abdulhalikov T; Erdogan HI; Altunbas G; Ozdemir K; Gok H
    J Thromb Thrombolysis; 2014 May; 37(4):483-9. PubMed ID: 24264959
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation.
    Ozturk G; Tavil B; Ozguner M; Ginis Z; Erden G; Tunc B; Azik MF; Uckan D; Delibas N
    J Clin Lab Anal; 2015 Jul; 29(4):259-62. PubMed ID: 24840114
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Heart-type fatty acid-binding protein and its relation with morphological changes in rat myocardial damage model induced by isoproterenol.
    Hasić S; Jadrić R; Cosović E; Kiseljaković E; Mornjaković Z; Winterhalter-Jadrić M
    Bosn J Basic Med Sci; 2011 Nov; 11(4):240-4. PubMed ID: 22117831
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Development of a Point-of-Care Test Based on Selenium Nanoparticles for Heart-Type Fatty Acid-Binding Proteins in Human Plasma and Blood.
    Wang L; Wu M; Ma J; Ma Z; Liang J; Tao N; Ren Y; Shao S; Qi X; Wang Z
    Int J Nanomedicine; 2022; 17():1273-1284. PubMed ID: 35345786
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Yuan M; Zang L; Xu A; Gong M; Liu Q; Huo B; Wang J; Fu H; Tse G; Roever L; Li G; Wang H; Liu T
    Front Pharmacol; 2021; 12():748677. PubMed ID: 34658887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.